NO20006547L - Salts of paroxetine - Google Patents

Salts of paroxetine

Info

Publication number
NO20006547L
NO20006547L NO20006547A NO20006547A NO20006547L NO 20006547 L NO20006547 L NO 20006547L NO 20006547 A NO20006547 A NO 20006547A NO 20006547 A NO20006547 A NO 20006547A NO 20006547 L NO20006547 L NO 20006547L
Authority
NO
Norway
Prior art keywords
paroxetine
salts
therapy
processes
preparation
Prior art date
Application number
NO20006547A
Other languages
Norwegian (no)
Other versions
NO20006547D0 (en
Inventor
Victor Witold Jacewicz
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20006547D0 publication Critical patent/NO20006547D0/en
Publication of NO20006547L publication Critical patent/NO20006547L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)

Abstract

Piperidin-forbindelser, fremgangsmåter for fremstilling av dem, farmasøytiske preparater omfattende dem og anvendelse av dem i terapi er beskrevet.Piperidine compounds, processes for their preparation, pharmaceutical compositions comprising them and their use in therapy are described.

NO20006547A 1998-07-02 2000-12-21 Salts of paroxetine NO20006547L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds
PCT/EP1999/004543 WO2000001692A1 (en) 1998-07-02 1999-06-30 Salts of paroxetine

Publications (2)

Publication Number Publication Date
NO20006547D0 NO20006547D0 (en) 2000-12-21
NO20006547L true NO20006547L (en) 2001-02-12

Family

ID=10834803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006547A NO20006547L (en) 1998-07-02 2000-12-21 Salts of paroxetine

Country Status (21)

Country Link
EP (1) EP1091958A1 (en)
JP (1) JP2002519421A (en)
KR (1) KR20010053337A (en)
CN (1) CN1314906A (en)
AP (1) AP2000002017A0 (en)
AU (2) AU4903999A (en)
BG (1) BG105204A (en)
BR (1) BR9911679A (en)
CA (1) CA2336470A1 (en)
CZ (1) CZ20004923A3 (en)
EA (1) EA200100098A1 (en)
GB (1) GB9814316D0 (en)
HU (1) HUP0103712A3 (en)
ID (1) ID27766A (en)
IL (1) IL140385A0 (en)
NO (1) NO20006547L (en)
PL (1) PL345365A1 (en)
SK (1) SK20242000A3 (en)
TR (1) TR200100055T2 (en)
WO (1) WO2000001692A1 (en)
ZA (2) ZA992899B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1622630T1 (en) 2003-05-07 2012-12-31 Osteologix A/S Strontium combinations for the prophylaxis/treatment of cartilage and/or bone conditions
ES2275218T3 (en) 2003-05-07 2007-06-01 Osteologix A/S HYDROSOLUBLE STRONTIUM SALTS FOR THE TREATMENT OF CARTILAGOS AND / OR BONE AFFECTIONS.
KR101165614B1 (en) 2004-02-26 2012-07-18 오스테올로지스 에이에스 Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
US7589235B2 (en) 2004-05-06 2009-09-15 Osteologix, A/S High yield and rapid synthesis methods for producing metallo-organic salts
KR100672184B1 (en) 2004-09-21 2007-01-19 주식회사종근당 Choline or Choline Derivative Salts of Paroxetine
JP2010504281A (en) * 2006-07-27 2010-02-12 エミスフェアー・テクノロジーズ・インク Arylsulfanyl compounds and compositions for delivering active agents
CN109212055B (en) * 2018-08-19 2021-05-07 丁立平 Gas chromatography-mass spectrometry combined method for determining four trace monohalogenated phenylacetic acids in drinking water
CN109342633B (en) * 2018-11-27 2020-10-02 北京市化工职业病防治院 Method for detecting metabolites of benzene, toluene and xylene in urine
CN111337460B (en) * 2018-12-18 2021-09-17 中国科学院大连化学物理研究所 High-stability Halo-tag probe and synthesis and biological application thereof
CN116283778B (en) * 2023-02-23 2025-08-29 江苏理工学院 A pyrazole carboxylic acid compound and its preparation method and application
US20250091996A1 (en) 2023-09-15 2025-03-20 King Faisal University 2-(1h-imidazole-1-carbonyl)benzoic acid as an anticancer compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
HU221921B1 (en) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them
EE03970B1 (en) * 1997-06-10 2003-02-17 Synthon B.V. 4-Phenylpiperidine Compound, its preparation and use, and medicament containing it
CA2319652A1 (en) * 1998-02-06 1999-08-12 Michael Urquhart Salts of paroxetine

Also Published As

Publication number Publication date
GB9814316D0 (en) 1998-09-02
ZA992899B (en) 2000-03-29
JP2002519421A (en) 2002-07-02
AP2000002017A0 (en) 2000-12-31
CZ20004923A3 (en) 2001-08-15
HUP0103712A3 (en) 2002-09-30
SK20242000A3 (en) 2001-07-10
IL140385A0 (en) 2002-02-10
PL345365A1 (en) 2001-12-17
AU2002100370A4 (en) 2002-06-06
NO20006547D0 (en) 2000-12-21
WO2000001692A1 (en) 2000-01-13
EP1091958A1 (en) 2001-04-18
HUP0103712A2 (en) 2002-05-29
AU4903999A (en) 2000-01-24
BR9911679A (en) 2002-01-29
BG105204A (en) 2001-11-30
CN1314906A (en) 2001-09-26
TR200100055T2 (en) 2001-07-23
ZA200100020B (en) 2002-03-25
KR20010053337A (en) 2001-06-25
CA2336470A1 (en) 2000-01-13
ID27766A (en) 2001-04-26
EA200100098A1 (en) 2001-08-27

Similar Documents

Publication Publication Date Title
ES2158778A1 (en) Paroxetine methanesulfonate
BR0016543A (en) New piperidine and piperazine derivatives
NO20002787L (en) New connections
NO20042161L (en) Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
NO20075066L (en) Pharmaceutical composition containing isoflavones
SE9904505D0 (en) Novel compounds
NO20006521L (en) 2- (purin-9-yl) -tetrahydrofuran-3,4-diol derivatives
MXPA02011304A (en) Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity.
NO20021328L (en) Pyrazolopyrimidia as therapeutic agents
NO20012774D0 (en) Preparation and method using essential plant oils
BR0314797A (en) Pyrimidineamide derivatives and their use
SE9900961D0 (en) Novel compounds
SE9802208D0 (en) Novel compounds
NO20020282D0 (en) New diphenylpiperidine derivative
BR0213994A (en) Heterocyclic Glycinamide Derivatives and Their Medical Uses
AP2000002017A0 (en) Salts of paroxetine.
NO20001934L (en) 3-Substituted tetrahydropyridopyrimidinone derivatives, their preparation and use
NO20026081L (en) New connections
SE9802209D0 (en) Novel compounds
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
NO982863L (en) New compounds with analgesic effect
NZ515531A (en) Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
ATE236885T1 (en) HYDRAZONO-BENZAZULENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND INTERMEDIATE PRODUCTS
NO20014803D0 (en) Pyrido-thienodiazepines, process for their preparation and pharmaceutical compositions containing them
NO20034985D0 (en) New 5-thio-SS-D-xylopyranoside derivatives, process for their preparation, pharmaceutical compositions containing them and the therapeutic use thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application